In melanoma, however, IL-6 exerts antitumor effects in the early stages of disease progression and later promotes tumor angiogenesis and the recruitment of immunosuppressive myeloid cells, such as MDSCs, to the TME [28]. This evidence concerns the gene IL6 and neoplasm.